A study found that HD patients with severe motor and non-motor symptoms (excluding chorea) had higher IL-2 levels compared to those with milder symptoms [68], suggesting that IL-2 elevation is linked to disease severity, which could explain the lack of CGA’s effect on IL-2 in our early-stage HD model. This evidence concerns the gene IL2 and Huntington disease.